The Valley Desk

NCT06852222 · Interventional trial

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Overall registry status Recruiting

Phase 3

Conditions Leukemia, Myeloid, Acute

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov